Simvastatin

Health written question – answered on 13th July 2005.

Alert me about debates like this

Photo of Paul Flynn Paul Flynn Labour, Newport West

To ask the Secretary of State for Health what percentage of the respondents to the consultation on the proposed reclassification of simvastatin as an over-the-counter drug were in favour of the proposal.

Photo of Jane Kennedy Jane Kennedy Minister of State, Department of Health

Of the 100 responses received, about one third were supportive of the proposal, one third opposed and one third were not opposed but raised issues. This was the position put to the Committee on Safety of Medicines (CSM), which also had access to the full responses when giving its advice. The consultation raised no issues not already considered by the CSM when their advice to consult on making simvastatin 10 milligrammes (mg) available over the counter was formulated. An error in the summary placed on the website following the announcement of the decision to allow simvastatin 10 mg to be sold in pharmacies had no bearing on the robustness of the deliberations of the CSM.

Responses received to the consultation on the proposed reclassification of simvastatin as an over-the-counter medicine have been made available electronically or summarised on the Medicines and Healthcare products Regulatory Agency's (MHRA) website at:

http://medicines.mhra.gov.uk/inforesources/publications/arm18 responses.htm.

To ensure complete transparency, the MHRA publishes the responses to all such consultations—most recently for chloramphenicol eye drops.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.